1,600
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Development of novel ALOX15 inhibitors combining dual machine learning filtering and fragment substitution optimisation approaches, molecular docking and dynamic simulation methods

, &
Article: 2301756 | Received 09 Jun 2023, Accepted 20 Dec 2023, Published online: 12 Jan 2024

References

  • Dixon SJ, Lemberg K, Fau-Lamprecht MR, Lamprecht MR, Fau-Skouta R, Skouta R, Fau-Zaitsev EM, Zaitsev EM, Fau-Gleason CE, Gleason CE, Fau-Patel DN, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060–1072.
  • Park E, Chung SW. ROS-mediated autophagy increases intracellular iron levels and ferroptosis by ferritin and transferrin receptor regulation.
  • Mahoney-Sánchez L, Bouchaoui H, Ayton S, Devos D, Duce JA, Devedjian JC. Ferroptosis and its potential role in the physiopathology of Parkinson’s Disease.
  • Ryan SK, Zelic M, Han YA, O.; Teeple E, Chen L, Sadeghi M, Shankara S, Guo L, Li C, Pontarelli F, Jensen, et al. Microglia ferroptosis is regulated by SEC24B and contributes to neurodegeneration. (1546-1726 (Electronic)).
  • Fang XA-O, Wang HA-O, Han D, Xie E, Yang X, Wei J, Gu S, Gao F, Zhu N, Yin X, et al. Ferroptosis as a target for protection against cardiomyopathy. (1091-6490 (Electronic)).
  • Kuang F, Liu J, Tang D, Kang R. Oxidative damage and antioxidant defense in ferroptosis. (2296-634X (Print)).
  • Sun QY, Zhou HH, Mao XA-O. Emerging roles of 5-lipoxygenase phosphorylation in inflammation and cell death. Oxid Med Cell Longevity. 2019;2019:2749173.
  • Singh NK, Rao GN. Emerging role of 12/15-Lipoxygenase (ALOX15) in human pathologies. (1873-2194 (Electronic)).
  • Ma XH, Liu JH, Liu CY, Sun WY, Duan WJ, Wang G, Kurihara H, He RR, Li YF, Chen Y, et al. ALOX15-launched PUFA-phospholipids peroxidation increases the susceptibility of ferroptosis in ischemia-induced myocardial damage. (2059-3635 (Electronic)).
  • Zhao J, Wu Y, Liang S, Piao X. Activation of SSAT1/ALOX15 Axis Aggravates Cerebral Ischemia/Reperfusion Injury via Triggering Neuronal Ferroptosis. (1873-7544 (Electronic)).
  • Gillmor SA, Villaseñor A Fau - Fletterick R, Fletterick R Fau - Sigal E, Sigal E Fau - Browner MF, Browner MF. The structure of mammalian 15-lipoxygenase reveals similarity to the lipases and the determinants of substrate specificity. (1072-8368 (Print)).
  • Choi J, Chon Jk Fau - Kim S, Kim S Fau - Shin W, Shin W. Conformational flexibility in mammalian 15S-lipoxygenase: Reinterpretation of the crystallographic data. (1097-0134 (Electronic)).
  • Schewe T Fau - Halangk W, Halangk W, Fau - Hiebsch C, Hiebsch C Fau - Rapoport SM, Rapoport SM. A lipoxygenase in rabbit reticulocytes which attacks phospholipids and intact mitochondria. (0014-5793 (Print)).
  • Belkner J, Wiesner R Fau - Kühn H, Kühn H, Fau - Lankin VZ, Lankin VZ. The oxygenation of cholesterol esters by the reticulocyte lipoxygenase. (0014-5793 (Print)).
  • Di Venere A, Horn T, Stehling S, Mei G, Masgrau L, González-Lafont À, Kühn H, Ivanov I. Role of Arg403 for thermostability and catalytic activity of rabbit 12/15-lipoxygenase. Biochim Biophys Acta. 2013;1831(6):1079–1088.
  • Ivanov I, Kuhn H, Heydeck D. Structural and functional biology of arachidonic acid 15-lipoxygenase-1 (ALOX15). Gene. 2015;573(1):1–32. (1879-0038 (Electronic)).
  • Ivanov IA-O, Cruz AA-O, Zhuravlev A, Di Venere A, Nicolai EA-O, Stehling S, Lluch JA-O, González-Lafont ÀA-O, Kuhn HA-O. Conformational heterogeneity and cooperative effects of mammalian ALOX15. IJMS. 2021;22(6):3285. LID - [doi] LID - 3285. (1422-0067 (Electronic)).
  • Guo H, Fau - Verhoek IC, Verhoek IC, Fau - Prins GGH, Prins GGH, Fau - van der Vlag R, van der Vlag RA-O, van der Wouden PE, Fau - van Merkerk R, van Merkerk R, Fau - Quax WJ, Quax WJ, Fau - Olinga P, Olinga P, Fau - Hirsch, et al. Novel 15-Lipoxygenase-1 Inhibitor Protects Macrophages from Lipopolysaccharide-Induced Cytotoxicity. (1520-4804 (Electronic)).
  • Ali SA, Awad SM, Said AM, Mahgoub S, Taha H, Ahmed NM. Design, synthesis, molecular modelling and biological evaluation of novel 3-(2-naphthyl)-1-phenyl-1H-pyrazole derivatives as potent antioxidants and 15-Lipoxygenase inhibitors. (1475-6374 (Electronic)).
  • Alavi SJ, Seyedi SM, Saberi S, Safdari H, Eshghi H, Sadeghian HA-O. Allylphenols as a new class of human 15-lipoxygenase-1 inhibitors. (1098-2299 (Electronic)).
  • Lei M, Liu Y, Fau - Zhu Y, Zhu Y, Fau - Liu Z, Liu Z. Progress of computer-aided drug design (CADD) of proteasome inhibitors. (1873-4294 (Electronic)).
  • Zhao L, Ciallella HL, Aleksunes LM, Zhu H. Advancing computer-aided drug discovery (CADD) by big data and data-driven machine learning modeling. (1878-5832 (Electronic)).
  • Villar HO, Hansen MR. Computational techniques in fragment based drug discovery. (1873-4294 (Electronic)).
  • Cruz A, Di Venere A, Mei G, Zhuravlev A, Golovanov A, Stehling S, Heydeck D, Lluch JM, González-Lafont À, Kuhn H, et al. A role of Gln596 in fine-tuning mammalian ALOX15 specificity, protein stability and allosteric properties. Biochim Biophys Acta Mol Cell Biol Lipids. 2020;1865(7):158680.
  • Lipinski CA. Chris Lipinski discusses life and chemistry after the Rule of Five. (1359-6446 (Print)).
  • Luo L, Wang H, Tian W, Zeng J, Huang Y, Luo H. Targeting ferroptosis for cancer therapy: iron metabolism and anticancer immunity. (2156-6976 (Print)).
  • Zhuravlev A, Golovanov A, Toporkov V, Kuhn H, Ivanov I. Functionalized Homologues and Positional Isomers of Rabbit 15- Lipoxygenase RS75091 Inhibitor. (1875-6638 (Electronic)).
  • Golovanov A, Zhuravlev A, Cruz A, Aksenov V, Shafiullina R, Kakularam KR, Lluch JA-O, Kuhn H, González-Lafont ÀA-O, Ivanov IA-O. N-Substituted 5-(1H-Indol-2-yl)-2-methoxyanilines Are Allosteric Inhibitors of the Linoleate Oxygenase Activity of Selected Mammalian ALOX15 Orthologs: Mechanism of Action. (1520-4804 (Electronic)).
  • Hosseinymehr M, Matin Mm Fau - Sadeghian H, Sadeghian H, Fau - Bahrami AR, Bahrami Ar Fau - Kaseb-Mojaver N, Kaseb-Mojaver N. 8-Farnesyloxycoumarin induces apoptosis in PC-3 prostate cancer cells by inhibition of 15-lipoxygenase-1 enzymatic activity. (1473-5741 (Electronic)).
  • Parvathaneni V, Kulkarni NS, Muth A, Gupta V. Drug repurposing: a promising tool to accelerate the drug discovery process. Drug Discov Today. 2019;24(10):2076–2085.
  • Garton AJ, Crew AP, Franklin M, Cooke AR, Wynne GM, Castaldo L, Kahler J, Winski SL, Franks A, Brown EN, et al. OSI-930: a novel selective inhibitor of Kit and kinase insert domain receptor tyrosine kinases with antitumor activity in mouse xenograft models. Cancer Res. 2006;66(2):1015–1024.
  • Uhl M, Aulwurm S Fau - Wischhusen J, Wischhusen J, Fau - Weiler M, Weiler M, Fau - Ma JY, Ma Jy Fau - Almirez R, Almirez R Fau - Mangadu R, Mangadu R Fau - Liu Y-W, Liu Yw Fau - Platten M, Platten M Fau - Herrlinger U, Herrlinger U, Fau - Murphy, et al. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo. (0008-5472 (Print)).
  • Schuster-Gaul S, Geisler LJ, McGeough MD, Johnson CD, Zagorska A, Li L, Wree A, Barry V, Mikaelian I, Jih LJ, et al. ASK1 inhibition reduces cell death and hepatic fibrosis in an Nlrp3 mutant liver injury model. JCI Insight. 2020;5(2):e123294.
  • Meng H, Dai Z, Zhang W, Liu Y, Lai L. Molecular mechanism of 15-lipoxygenase allosteric activation and inhibition. Phys Chem Chem Phys. 2018;20(21):14785–14795.
  • Bellamy H, Rehim AA, Orhobor OI, King R. Batched Bayesian optimization for drug design in noisy environments. J Chem Inf Model. 2022;62(17):3970–3981.
  • Amin SA, Adhikari N, Jha T. Development of decision trees to discriminate HDAC8 inhibitors and non-inhibitors using recursive partitioning. J Biomol Struct Dyn. 2021;39(1):1–8.
  • Ding X, Wu Y, Wang Y, Vilseck JZ, Brooks CL. 3rd, Accelerated CDOCKER with GPUs, Parallel Simulated Annealing, and Fast Fourier Transforms. J Chem Theory Comput. 2020;16(6):3910–3919.
  • Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017;7(1):42717.
  • Prival MJ. Evaluation of the TOPKAT system for predicting the carcinogenicity of chemicals. (0893-6692 (Print)).
  • Sousa da Silva AW, Vranken WF. ACPYPE - AnteChamber PYthon Parser interface. (1756-0500 (Electronic)).
  • Van Der Spoel D, Lindahl E, Hess B, Groenhof G, Mark AE, Berendsen HJ. GROMACS: fast, flexible, and free. J Comput Chem. 2005;26(16):1701–1718.
  • Kumari R, Kumar R, Lynn A. g_mmpbsa–a GROMACS tool for high-throughput MM-PBSA calculations. (1549-960X (Electronic)).